会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明公开
    • GLYCOSYLATION MODIFIED IL-20
    • 糖基化修饰的IL-20
    • EP1587904A2
    • 2005-10-26
    • EP03791607.9
    • 2003-08-14
    • ELI LILLY AND COMPANY
    • GREALISH, Patrick, FrancisROWLINSON, Scott, William
    • C12N1/00
    • C07K14/54A61K38/00C07K2319/91
    • This invention relates to glycosylation-modified IL-20 polypeptides which preferentially signal through one of the multiple IL-20 receptor complexes and maintain at least one activity associated with wild type IL-20 while decreasing or eliminating at least one other activity associated with wild type IL-20. The N-linked consensus glycosylation sites are engineered into IL-20 at one or more sites which correspond to an N-linked consensus glycosylation site that exists in wild type IL-19 or IL-24. The invention also relates to polynucleotides encoding the polypeptides of the invention, vectors and host cells comprising a polynucleotide of the invention, and therapeutic methods for using the polypeptides and polynucleotides of the invention.
    • 本发明涉及糖基化修饰的IL-20多肽,其优先通过多种IL-20受体复合物之一发出信号并维持至少一种与野生型IL-20相关的活性,同时降低或消除至少一种与野生型相关的其他活性 IL-20。 N-连接的共有糖基化位点在对应于存在于野生型IL-19或IL-24中的N-连接共有糖基化位点的一个或多个位点处被工程化为IL-20。 本发明还涉及编码本发明多肽的多核苷酸,包含本发明多核苷酸的载体和宿主细胞,以及使用本发明多肽和多核苷酸的治疗方法。